Information displayed below is a subset of the entire knowledge base and may be incorrect, or incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.
Antithrombin III deficiency is a rare inherited disorder that affects the body's ability to control blood clotting. It is caused by a deficiency of the protein antithrombin III, which is responsible for preventing the formation of blood clots. People with this disorder are at an increased risk of developing blood clots in their veins and arteries, which can lead to serious complications such as stroke, heart attack, and pulmonary embolism. Treatment typically involves anticoagulant medications to reduce the risk of clotting.
All of the following must be considered when interpreting
clinical findings and are too extensive to be covered on
this site: